Correction: Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML.
Publication/Presentation Date
11-1-2021
Volume
56
Issue
11
First Page
2871
Last Page
2871
ISSN
1476-5365
Published In/Presented At
Krieger, E., Qayyum, R., Keating, A., & Toor, A. (2021). Correction: Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML. Bone marrow transplantation, 56(11), 2871. https://doi.org/10.1038/s41409-021-01488-3
Disciplines
Medicine and Health Sciences
PubMedID
34654887
Department(s)
Department of Medicine, Hematology-Medical Oncology Division
Document Type
Article
COinS